Skip to main content

Search

Clear
Filter by Type
Filter by Topics
Filter by Symptoms & Conditions
Filter by Year

APTA Results (4,741 Results)

Includes articles, courses, and CPGs. Unlimited access for APTA members.

Mercer-Marquette Challenge Deadline: April 26

Mar 28, 2018/Article

The Challenge is celebrating its 30th anniversary.

Bill Allowing PTAs in TRICARE Ready for President's Signature

Nov 16, 2017/News

"This is a significant win for PTAs, but an even bigger win for patients in the TRICARE program."

Motor Growth Curves for Cerebral Palsy

Jan 21, 2013/Test & Measure

Target population: People with cerebral palsy (CP).

Pediatric Quality of Life Inventory (PQoL) for Cerebral Palsy (CP)

Jan 21, 2013/Test & Measure

Target population: People with cerebral palsy (CP).

American Academy of Orthopaedic Surgeons: Management of Osteoarthritis of the Knee (Non-Arthroplasty)

Aug 31, 2021/CPG

This guideline focuses specifically on the non-arthroplasty treatment of osteoarthritis of the knee. It does not cover osteoarthritis of other joints, rheumatoid arthritis, or other inflammatory disorders. This replaces 2013 appropriate use criteria. 

Measuring by Value, Not Volume

Jul 1, 2015/Feature

APTA Magazine explored the trend toward employer-established productivity standards, with a focus on implications for the profession and physical therapists.

Directory of Postdoctoral Programs

Feb 12, 2026/Open Access

The postdoctoral programs listed provide opportunities for research and education post academic doctoral degree (ie, PhD) for PTs.

Responding to Patient Concerns About Workers' Comp During the COVID-19 Pandemic

Mar 31, 2020/News

Some patients may be understandably concerned about losing WC benefits if they choose to reduce travel during the national health emergency.

5 Times Sit to Stand Test (FTSST)

Jun 2, 2014/Test & Measure

Five Times Sit to Stand Test (FTSST)

CMS: Private Practices Must Continue Direct Supervision of PTAs Providing RTM

Jan 23, 2023/News

APTA advised private practice PTs to continue direct supervision for PTA use of remote therapeutic monitoring until CMS clarified the issue.